Royal Bank of Canada’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.23M | Sell |
|
|||||
|
2025
Q2 | $5.78M | Buy |
|
|||||
|
2025
Q1 | $934K | Buy |
|
|||||
|
2024
Q4 | $630K | Sell |
|
|||||
|
2024
Q3 | $756K | Buy |
|
|||||
|
2024
Q2 | $636K | Buy |
|
|||||
|
2024
Q1 | $590K | Sell |
|
|||||
|
2023
Q4 | $599K | Buy |
|
|||||
|
2023
Q3 | $507K | Buy |
|
|||||
|
2023
Q2 | $446K | Buy |
|
|||||
|
2023
Q1 | $441K | Sell |
|
|||||
|
2022
Q4 | $539K | Buy |
|
|||||
|
2022
Q3 | $451K | Sell |
|
|||||
|
2022
Q2 | $536K | Buy |
|
|||||
|
2022
Q1 | $601K | Sell |
|
|||||
|
2021
Q4 | $726K | Buy |
|
|||||
|
2021
Q3 | $704K | Sell |
|
|||||
|
2021
Q2 | $843K | Buy |
|
|||||
|
2021
Q1 | $752K | Buy |
|
|||||
|
2020
Q4 | $704K | Sell |
|
|||||
|
2020
Q3 | $715K | Buy |
|
|||||
|
2020
Q2 | $567K | Sell |
|
|||||
|
2020
Q1 | $575K | Buy |
|
|||||
|
2019
Q4 | $621K | Buy |
|
|||||
|
2019
Q3 | $530K | Buy |
|
|||||
|
2019
Q2 | $518K | Sell |
|
|||||
|
2019
Q1 | $530K | Buy |
|
|||||
|
2018
Q4 | $331K | Buy |
|
|||||
|
2018
Q3 | $341K | Sell |
|
|||||
|
2018
Q2 | $336K | Sell |
|
|||||
|
2018
Q1 | $402K | Sell |
|
|||||
|
2017
Q4 | $449K | Sell |
|
|||||
|
2017
Q3 | $624K | Buy |
|
|||||
|
2017
Q2 | $403K | Buy |
|
|||||
|
2017
Q1 | $335K | Buy |
|
|||||
|
2016
Q4 | $239K | Buy |
|
|||||
|
2016
Q3 | $219K | Sell |
|
|||||
|
2016
Q2 | $234K | Buy |
|
|||||
|
2016
Q1 | $217K | Sell |
|
|||||
|
2015
Q4 | $385K | Buy |
|
|||||
|
2015
Q3 | $300K | Sell |
|
|||||
|
2015
Q2 | $415K | Sell |
|
|||||
|
2015
Q1 | $649K | Sell |
|
|||||
|
2014
Q4 | $717K | Sell |
|
|||||
|
2014
Q3 | $657K | Buy |
|
|||||
|
2014
Q2 | $397K | Buy |
|
|||||
|
2014
Q1 | $348K | Sell |
|
|||||
|
2013
Q4 | $343K | Buy |
|
|||||
|
2013
Q3 | $317K | Sell |
|
|||||
|
2013
Q2 | $341K | Buy |
|